Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Panitumumab

  • You have access
    Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study
    CHIH-CHIEN WU, CHIEN-CHOU SU, YU-HSUN CHEN, CHAO-WEN HSU, MENG-CHE HSIEH, YU-CHING CHANG, YUNG-CHANG WANG and YI-CHIA SU
    Anticancer Research November 2023, 43 (11) 5127-5138; DOI: https://doi.org/10.21873/anticanres.16713
  • You have access
    Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer
    MICHIO KIMURA, EISEKI USAMI and TOMOAKI YOSHIMURA
    Anticancer Research December 2020, 40 (12) 7135-7140; DOI: https://doi.org/10.21873/anticanres.14743
  • You have access
    The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents
    ONDREJ FIALA, PAVEL OSTASOV, PETR HOSEK, ONDREJ SOREJS, VACLAV LISKA, TOMAS BUCHLER, ALEXANDR POPRACH, RADEK KUCERA, ONDREJ TOPOLCAN, JAN SUSTR, MONIKA SEDIVCOVA and JINDRICH FINEK
    Anticancer Research October 2019, 39 (10) 5645-5652; DOI: https://doi.org/10.21873/anticanres.13761
  • You have access
    Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
    IGOR KISS, JITKA MLCOCHOVA, ZBYNEK BORTLICEK, ALEXANDR POPRACH, JIRI DRABEK, PETRA VYCHYTILOVA-FALTEJSKOVA, MAREK SVOBODA, TOMAS BUCHLER, STANISLAV BATKO, ALES RYSKA, MARIAN HAJDUCH and ONDREJ SLABY
    Anticancer Research September 2016, 36 (9) 4955-4959;
  • You have access
    Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer
    TOSHIFUMI YAMAGUCHI, SATORU IWASA, KENGO NAGASHIMA, NOBUAKI IKEZAWA, TETSUYA HAMAGUCHI, HIROKAZU SHOJI, YOSHITAKA HONMA, ATSUO TAKASHIMA, NATSUKO OKITA, KEN KATO, YASUHIDE YAMADA and YASUHIRO SHIMADA
    Anticancer Research July 2016, 36 (7) 3531-3536;
  • You have access
    Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients
    MAYA YAMADA, HIROTOSHI IIHARA, HIRONORI FUJII, MASASHI ISHIHARA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUHIRO YOSHIDA and YOSHINORI ITOH
    Anticancer Research November 2015, 35 (11) 6175-6181;
  • You have access
    Epistaxis Secondary to Panitumumab in a Patient with Colon Cancer
    DAVIDA A. KORNREICH and M. WASIF SAIF
    Anticancer Research November 2012, 32 (11) 4983-4985;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire